drugset / Trial / NCT06631625

Effect of Addition of Dexmedetomidine or Ketamine to Intravenous Infusion of Lidocaine on Proinflammatory Cytokines in Pelvi-abdominal Cancer Surgeries.

NCT06631625

Phase 1 Completed 45 enrolled Alexandria University
RandomizedParallel-groupSingle-blindHealth-services research

Summary

The investigators hypothesize that effect of addition of dexmedetomidine or ketamine by IV infusion to lidocaine infusion may be more beneficial than lidocaine infusion alone on proinflammatory cytokines (IL-1, IL-6 and TNFα), and postoperative pain relief and decreased opioid consumption, reduced Length of stay.

Timeline

Start
2023-09-24
Primary completion
2024-09-24
Completion
2024-09-24

Publications

  • Results Hassan MM, Saleh RG, Abdalla NO, Radwan NH, Abdelghfar EM. Effect of lidocaine infusion compared to dexmedetomidine infusion on proinflammatory cytokines and stress response in pelvi-abdominal cancer surgeries: a randomized clinical trial. Anaesth. pain intensive care 2021;26 (1):44-52. DOI: 10.35975/apic.v26i1.1765

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.4 ug/kg Intravenous
Subject Ketamine Small molecule 0.2 mg/kg Intravenous
Background Lidocaine Other / unclassified 1.5 mg/kg Intravenous

Indications

No indication recorded.